Skip header and go to main content

Classification Resources
 
Class   514DRUG, BIO-AFFECTING AND BODY TREATING COMPOSITIONS
Click here for a printable version of this file
  Turn Outline  
     Expand/Contract Processing Please Wait
This Class 514 is considered to be an integral part of Class 424 (see the Class 424 schedule for the position of this Class in schedule hierarchy). This Class retains all pertinent definitions and class lines of Class 424.
[List of Pre Grant Publications for class 514 subclass 1][List of Patents for class 514 subclass 1]1 DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI)
[List of Pre Grant Publications for class 514 subclass 1.1][List of Patents for class 514 subclass 1.1]1.1 Subclass 1.1 indent level is 1 Peptide (e.g., protein, etc.) containing DOAI
 [List of Pre Grant Publications for class 514 subclass 1.2][List of Patents for class 514 subclass 1.2]1.2 Subclass 1.2 indent level is 2 Transporter affecting or utilizing
 [List of Pre Grant Publications for class 514 subclass 1.3][List of Patents for class 514 subclass 1.3]1.3 Subclass 1.3 indent level is 2 Prodrug utilizing
 [List of Pre Grant Publications for class 514 subclass 1.4][List of Patents for class 514 subclass 1.4]1.4 Subclass 1.4 indent level is 2 Sepsis affecting
 [List of Pre Grant Publications for class 514 subclass 1.5][List of Patents for class 514 subclass 1.5]1.5 Subclass 1.5 indent level is 2 Respiratory distress syndrome (e.g., ARDS, IRDS, etc.) affecting
 [List of Pre Grant Publications for class 514 subclass 1.6][List of Patents for class 514 subclass 1.6]1.6 Subclass 1.6 indent level is 2 Pneumonia affecting
 [List of Pre Grant Publications for class 514 subclass 1.7][List of Patents for class 514 subclass 1.7]1.7 Subclass 1.7 indent level is 2 Asthma affecting
 [List of Pre Grant Publications for class 514 subclass 1.8][List of Patents for class 514 subclass 1.8]1.8 Subclass 1.8 indent level is 2 Cystic fibrosis affecting
 [List of Pre Grant Publications for class 514 subclass 1.9][List of Patents for class 514 subclass 1.9]1.9 Subclass 1.9 indent level is 2 Arteriosclerosis (e.g., atherosclerosis, etc.) affecting
 [List of Pre Grant Publications for class 514 subclass 2.1][List of Patents for class 514 subclass 2.1]2.1 Subclass 2.1 indent level is 2 Endotoxin (e.g., LPS, etc.) affecting
 [List of Pre Grant Publications for class 514 subclass 2.2][List of Patents for class 514 subclass 2.2]2.2 Subclass 2.2 indent level is 2 Bactericidal/permeability-increasing (BPI) protein affecting or utilizing
[List of Pre Grant Publications for class 514 subclass 2.3][List of Patents for class 514 subclass 2.3]2.3 Subclass 2.3 indent level is 2 Micro-organism destroying or inhibiting
 [List of Pre Grant Publications for class 514 subclass 4.5][List of Patents for class 514 subclass 4.5]4.5 Subclass 4.5 indent level is 2 Insect destroying or inhibiting
 [List of Pre Grant Publications for class 514 subclass 4.6][List of Patents for class 514 subclass 4.6]4.6 Subclass 4.6 indent level is 2 Parasite (e.g., tapeworm, roundworm, nematode, etc.) destroying or inhibiting
 [List of Pre Grant Publications for class 514 subclass 4.7][List of Patents for class 514 subclass 4.7]4.7 Subclass 4.7 indent level is 2 Lactation affecting
[List of Pre Grant Publications for class 514 subclass 4.8][List of Patents for class 514 subclass 4.8]4.8 Subclass 4.8 indent level is 2 Weight regulation affecting
 [List of Pre Grant Publications for class 514 subclass 5.4][List of Patents for class 514 subclass 5.4]5.4 Subclass 5.4 indent level is 2 Iron affecting
[List of Pre Grant Publications for class 514 subclass 5.5][List of Patents for class 514 subclass 5.5]5.5 Subclass 5.5 indent level is 2 Nutrition enhancement or support
 [List of Pre Grant Publications for class 514 subclass 5.8][List of Patents for class 514 subclass 5.8]5.8 Subclass 5.8 indent level is 2 Leptin or derivative affecting or utilizing
[List of Pre Grant Publications for class 514 subclass 5.9][List of Patents for class 514 subclass 5.9]5.9 Subclass 5.9 indent level is 2 Insulin or derivative utilizing
 [List of Pre Grant Publications for class 514 subclass 6.7][List of Patents for class 514 subclass 6.7]6.7 Subclass 6.7 indent level is 2 Insulin affecting
[List of Pre Grant Publications for class 514 subclass 6.8][List of Patents for class 514 subclass 6.8]6.8 Subclass 6.8 indent level is 2 Blood sugar affecting
 [List of Pre Grant Publications for class 514 subclass 7.4][List of Patents for class 514 subclass 7.4]7.4 Subclass 7.4 indent level is 2 Lipid or cholesterol affecting (e.g., dyslipidemia, etc.)
 [List of Pre Grant Publications for class 514 subclass 7.5][List of Patents for class 514 subclass 7.5]7.5 Subclass 7.5 indent level is 2 Protein tyrosine kinase (PTK) affecting
[List of Pre Grant Publications for class 514 subclass 7.6][List of Patents for class 514 subclass 7.6]7.6 Subclass 7.6 indent level is 2 Growth factor or derivative affecting or utilizing
[List of Pre Grant Publications for class 514 subclass 9.7][List of Patents for class 514 subclass 9.7]9.7 Subclass 9.7 indent level is 2 Hormone or derivative affecting or utilizing
 [List of Pre Grant Publications for class 514 subclass 13.2][List of Patents for class 514 subclass 13.2]13.2 Subclass 13.2 indent level is 2 Digestive tract ulcer affecting
 [List of Pre Grant Publications for class 514 subclass 13.3][List of Patents for class 514 subclass 13.3]13.3 Subclass 13.3 indent level is 2 Angiogenesis affecting
 [List of Pre Grant Publications for class 514 subclass 13.4][List of Patents for class 514 subclass 13.4]13.4 Subclass 13.4 indent level is 2 Blood substitute
[List of Pre Grant Publications for class 514 subclass 13.5][List of Patents for class 514 subclass 13.5]13.5 Subclass 13.5 indent level is 2 Blood affecting or blood protein utilizing
 [List of Pre Grant Publications for class 514 subclass 15.4][List of Patents for class 514 subclass 15.4]15.4 Subclass 15.4 indent level is 2 Kidney affecting
 [List of Pre Grant Publications for class 514 subclass 15.5][List of Patents for class 514 subclass 15.5]15.5 Subclass 15.5 indent level is 2 Surfactant protein (e.g., SP-A, SP-B, etc.) or derivative affecting or utilizing
[List of Pre Grant Publications for class 514 subclass 15.6][List of Patents for class 514 subclass 15.6]15.6 Subclass 15.6 indent level is 2 Blood pressure affecting
 [List of Pre Grant Publications for class 514 subclass 16.3][List of Patents for class 514 subclass 16.3]16.3 Subclass 16.3 indent level is 2 Angiotensin converting enzyme (ACE) affecting
 [List of Pre Grant Publications for class 514 subclass 16.4][List of Patents for class 514 subclass 16.4]16.4 Subclass 16.4 indent level is 2 Cardiac disease (i.e., heart disease) affecting
 [List of Pre Grant Publications for class 514 subclass 16.5][List of Patents for class 514 subclass 16.5]16.5 Subclass 16.5 indent level is 2 Tissue development affecting
 [List of Pre Grant Publications for class 514 subclass 16.6][List of Patents for class 514 subclass 16.6]16.6 Subclass 16.6 indent level is 2 Rheumatoid arthritis affecting
[List of Pre Grant Publications for class 514 subclass 16.7][List of Patents for class 514 subclass 16.7]16.7 Subclass 16.7 indent level is 2 Bone affecting
 [List of Pre Grant Publications for class 514 subclass 17.1][List of Patents for class 514 subclass 17.1]17.1 Subclass 17.1 indent level is 2 Cartilage affecting
 [List of Pre Grant Publications for class 514 subclass 17.2][List of Patents for class 514 subclass 17.2]17.2 Subclass 17.2 indent level is 2 Collagen or derivative affecting or utilizing
 [List of Pre Grant Publications for class 514 subclass 17.3][List of Patents for class 514 subclass 17.3]17.3 Subclass 17.3 indent level is 2 N-methyl-d-aspartate (NMDA) receptor affecting
 [List of Pre Grant Publications for class 514 subclass 17.4][List of Patents for class 514 subclass 17.4]17.4 Subclass 17.4 indent level is 2 Ion channel protein affecting
[List of Pre Grant Publications for class 514 subclass 17.5][List of Patents for class 514 subclass 17.5]17.5 Subclass 17.5 indent level is 2 Mental disorder or mental illness (e.g., psychoses, etc.) affecting
[List of Pre Grant Publications for class 514 subclass 17.7][List of Patents for class 514 subclass 17.7]17.7 Subclass 17.7 indent level is 2 Nervous system (e.g., central nervous system (CNS), etc.) affecting
[List of Pre Grant Publications for class 514 subclass 18.6][List of Patents for class 514 subclass 18.6]18.6 Subclass 18.6 indent level is 2 Skin affecting
 [List of Pre Grant Publications for class 514 subclass 18.9][List of Patents for class 514 subclass 18.9]18.9 Subclass 18.9 indent level is 2 Apoptosis affecting
 [List of Pre Grant Publications for class 514 subclass 19.1][List of Patents for class 514 subclass 19.1]19.1 Subclass 19.1 indent level is 2 Cellular adhesion affecting or cell adhesion molecule (CAM) affecting or utilizing
[List of Pre Grant Publications for class 514 subclass 19.2][List of Patents for class 514 subclass 19.2]19.2 Subclass 19.2 indent level is 2 Neoplastic condition affecting
[List of Pre Grant Publications for class 514 subclass 20.1][List of Patents for class 514 subclass 20.1]20.1 Subclass 20.1 indent level is 2 Protease inhibitor affecting or utilizing
 [List of Pre Grant Publications for class 514 subclass 20.5][List of Patents for class 514 subclass 20.5]20.5 Subclass 20.5 indent level is 2 Cyclosporine or derivative utilizing
 [List of Pre Grant Publications for class 514 subclass 20.6][List of Patents for class 514 subclass 20.6]20.6 Subclass 20.6 indent level is 2 G-protein coupled receptor (GPCR) affecting
 [List of Pre Grant Publications for class 514 subclass 20.7][List of Patents for class 514 subclass 20.7]20.7 Subclass 20.7 indent level is 2 Hair affecting
 [List of Pre Grant Publications for class 514 subclass 20.8][List of Patents for class 514 subclass 20.8]20.8 Subclass 20.8 indent level is 2 Eye affecting
 [List of Pre Grant Publications for class 514 subclass 20.9][List of Patents for class 514 subclass 20.9]20.9 Subclass 20.9 indent level is 2 Glycopeptide utilizing
 [List of Pre Grant Publications for class 514 subclass 21.1][List of Patents for class 514 subclass 21.1]21.1 Subclass 21.1 indent level is 2 Cyclopeptide utilizing
 [List of Pre Grant Publications for class 514 subclass 21.2][List of Patents for class 514 subclass 21.2]21.2 Subclass 21.2 indent level is 2 100 or more amino acid residues in the peptide chain
 [List of Pre Grant Publications for class 514 subclass 21.3][List of Patents for class 514 subclass 21.3]21.3 Subclass 21.3 indent level is 2 25 to 99 amino acid residues in the peptide chain
 [List of Pre Grant Publications for class 514 subclass 21.4][List of Patents for class 514 subclass 21.4]21.4 Subclass 21.4 indent level is 2 16 to 24 amino acid residues in the peptide chain
 [List of Pre Grant Publications for class 514 subclass 21.5][List of Patents for class 514 subclass 21.5]21.5 Subclass 21.5 indent level is 2 12 to 15 amino acid residues in the peptide chain
 [List of Pre Grant Publications for class 514 subclass 21.6][List of Patents for class 514 subclass 21.6]21.6 Subclass 21.6 indent level is 2 9 to 11 amino acid residues in the peptide chain
 [List of Pre Grant Publications for class 514 subclass 21.7][List of Patents for class 514 subclass 21.7]21.7 Subclass 21.7 indent level is 2 7 or 8 amino acid residues in the peptide chain
 [List of Pre Grant Publications for class 514 subclass 21.8][List of Patents for class 514 subclass 21.8]21.8 Subclass 21.8 indent level is 2 5 or 6 amino acid residues in the peptide chain
 [List of Pre Grant Publications for class 514 subclass 21.9][List of Patents for class 514 subclass 21.9]21.9 Subclass 21.9 indent level is 2 3 or 4 amino acid residues in the peptide chain
 [List of Pre Grant Publications for class 514 subclass 21.91][List of Patents for class 514 subclass 21.91]21.91 Subclass 21.91 indent level is 2 2 amino acid residues in the peptide chain
 [List of Pre Grant Publications for class 514 subclass 21.92][List of Patents for class 514 subclass 21.92]21.92 Subclass 21.92 indent level is 2 Produced by or extracted from animal tissue
 [List of Pre Grant Publications for class 514 subclass 22][List of Patents for class 514 subclass 22]22 Subclass 22 indent level is 1 Lignin or derivative DOAI
[List of Pre Grant Publications for class 514 subclass 23][List of Patents for class 514 subclass 23]23 Subclass 23 indent level is 1 Carbohydrate (i.e., saccharide radical containing) DOAI
 [List of Pre Grant Publications for class 514 subclass 24][List of Patents for class 514 subclass 24]24 Subclass 24 indent level is 2 S-glycoside
[List of Pre Grant Publications for class 514 subclass 25][List of Patents for class 514 subclass 25]25 Subclass 25 indent level is 2 O-glycoside
[List of Pre Grant Publications for class 514 subclass 42][List of Patents for class 514 subclass 42]42 Subclass 42 indent level is 2 N-glycoside
 [List of Pre Grant Publications for class 514 subclass 53][List of Patents for class 514 subclass 53]53 Subclass 53 indent level is 2 Dissacharide
[List of Pre Grant Publications for class 514 subclass 54][List of Patents for class 514 subclass 54]54 Subclass 54 indent level is 2 Polysaccharide
 [List of Pre Grant Publications for class 514 subclass 62][List of Patents for class 514 subclass 62]62 Subclass 62 indent level is 2 Glucosamine or derivative
 [List of Pre Grant Publications for class 514 subclass 63][List of Patents for class 514 subclass 63]63 Subclass 63 indent level is 1 Silicon containing DOAI
 [List of Pre Grant Publications for class 514 subclass 64][List of Patents for class 514 subclass 64]64 Subclass 64 indent level is 1 Boron containing DOAI
[List of Pre Grant Publications for class 514 subclass 65][List of Patents for class 514 subclass 65]65 Subclass 65 indent level is 1 Pyrethrum plant derived material or plant derived rotenone compound containing DOAI
[List of Pre Grant Publications for class 514 subclass 75][List of Patents for class 514 subclass 75]75 Subclass 75 indent level is 1 Phosphorus containing other than solely as part of an inorganic ion in an addition salt DOAI
 [List of Pre Grant Publications for class 514 subclass 76][List of Patents for class 514 subclass 76]76 Subclass 76 indent level is 2 Amine addition salt of organic phosphorus containing acid
[List of Pre Grant Publications for class 514 subclass 77][List of Patents for class 514 subclass 77]77 Subclass 77 indent level is 2 Inner salt (e.g., betaine, etc.)
[List of Pre Grant Publications for class 514 subclass 79][List of Patents for class 514 subclass 79]79 Subclass 79 indent level is 2 Nitrogen containing hetero ring
[List of Pre Grant Publications for class 514 subclass 95][List of Patents for class 514 subclass 95]95 Subclass 95 indent level is 2 Sulfur containing hetero ring
[List of Pre Grant Publications for class 514 subclass 99][List of Patents for class 514 subclass 99]99 Subclass 99 indent level is 2 Oxygen containing hetero ring
[List of Pre Grant Publications for class 514 subclass 102][List of Patents for class 514 subclass 102]102 Subclass 102 indent level is 2 Two or more phosphorus atoms directly or indirectly bonded together by only covalent bonds
 [List of Pre Grant Publications for class 514 subclass 109][List of Patents for class 514 subclass 109]109 Subclass 109 indent level is 2 P-X-X containing (X is chalcogen)
[List of Pre Grant Publications for class 514 subclass 110][List of Patents for class 514 subclass 110]110 Subclass 110 indent level is 2 Phosphorus is part of a ring
[List of Pre Grant Publications for class 514 subclass 112][List of Patents for class 514 subclass 112]112 Subclass 112 indent level is 2 Cyano or isocyano containing
[List of Pre Grant Publications for class 514 subclass 114][List of Patents for class 514 subclass 114]114 Subclass 114 indent level is 2 Nitrogen, other than nitro or nitroso, bonded indirectly to phosphorus
[List of Pre Grant Publications for class 514 subclass 120][List of Patents for class 514 subclass 120]120 Subclass 120 indent level is 2 C=O other than as ketone or aldehyde, attached directly or indirectly to phosphorus
 [List of Pre Grant Publications for class 514 subclass 125][List of Patents for class 514 subclass 125]125 Subclass 125 indent level is 2 Ketone or aldehyde containing
[List of Pre Grant Publications for class 514 subclass 126][List of Patents for class 514 subclass 126]126 Subclass 126 indent level is 2 Sulfur not bonded directly to phosphorus
[List of Pre Grant Publications for class 514 subclass 129][List of Patents for class 514 subclass 129]129 Subclass 129 indent level is 2 Oxygen bonded directly to a carbon or hydrogen and wherein the oxygen is not bonded directly to phosphorus
[List of Pre Grant Publications for class 514 subclass 131][List of Patents for class 514 subclass 131]131 Subclass 131 indent level is 2 Nitro group bonded to a carbon
[List of Pre Grant Publications for class 514 subclass 134][List of Patents for class 514 subclass 134]134 Subclass 134 indent level is 2 Acyclic carbon to carbon unsaturation
[List of Pre Grant Publications for class 514 subclass 137][List of Patents for class 514 subclass 137]137 Subclass 137 indent level is 2 Nitrogen bonded directly to phosphorus
 [List of Pre Grant Publications for class 514 subclass 139][List of Patents for class 514 subclass 139]139 Subclass 139 indent level is 2 Phosphorus bonded directly to halogen
 [List of Pre Grant Publications for class 514 subclass 140][List of Patents for class 514 subclass 140]140 Subclass 140 indent level is 2 (C)(R)P=X(-XC) containing (i.e., Phosphinate (X is chalcogen; R is C or H)
 [List of Pre Grant Publications for class 514 subclass 141][List of Patents for class 514 subclass 141]141 Subclass 141 indent level is 2 (CX-) (C)P=X(XH) or (CX-) (R)P=X(XC) containing (e.g., phosphonate, etc.) (X is chalcogen; R is C or H)
 [List of Pre Grant Publications for class 514 subclass 142][List of Patents for class 514 subclass 142]142 Subclass 142 indent level is 2 (CX-)(C)P(C),(CX-)(RX-)P(C),(CX-)P(XH)(XH) or (CX-)(CX-)P(-XR) containing (X is chalcogen; R is C or H) (e.g., phosphinite, phosphite, etc.)
[List of Pre Grant Publications for class 514 subclass 143][List of Patents for class 514 subclass 143]143 Subclass 143 indent level is 2 Ester of (HX)P=X(XH)(XH) (X is chalcogen) (e.g., phosphate, etc.)
 [List of Pre Grant Publications for class 514 subclass 149][List of Patents for class 514 subclass 149]149 Subclass 149 indent level is 1 Azoxy DOAI
[List of Pre Grant Publications for class 514 subclass 150][List of Patents for class 514 subclass 150]150 Subclass 150 indent level is 1 Acyclic nitrogen double bonded to acyclic nitrogen, acyclic nitrogen triple bonded to acyclic nitrogen or azide DOAI
[List of Pre Grant Publications for class 514 subclass 152][List of Patents for class 514 subclass 152]152 Subclass 152 indent level is 1 3,10-dihydroxy-2-naphthacene carboxamide or derivative (e.g., tetracycline, etc.) DOAI
[List of Pre Grant Publications for class 514 subclass 155][List of Patents for class 514 subclass 155]155 Subclass 155 indent level is 1 Para-N-benzene - sulfoxy-N containing DOAI, and said benzene ring is not part of a polycyclo ring system
[List of Pre Grant Publications for class 514 subclass 159][List of Patents for class 514 subclass 159]159 Subclass 159 indent level is 1 Ortho-hydroxybenzoic acid (i.e., salicyclic acid) or derivative DOAI
[List of Pre Grant Publications for class 514 subclass 167][List of Patents for class 514 subclass 167]167 Subclass 167 indent level is 1 9,10-seco- cyclopentanohydrophenanthrene ring system (e.g., vitamin D, etc.) DOAI
[List of Pre Grant Publications for class 514 subclass 169][List of Patents for class 514 subclass 169]169 Subclass 169 indent level is 1 Cyclopentanohydrophenanthrene ring system DOAI
[List of Pre Grant Publications for class 514 subclass 183][List of Patents for class 514 subclass 183]183 Subclass 183 indent level is 1 Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI
[List of Pre Grant Publications for class 514 subclass 184][List of Patents for class 514 subclass 184]184 Subclass 184 indent level is 2 Heavy metal containing (including salts)
 [List of Pre Grant Publications for class 514 subclass 191][List of Patents for class 514 subclass 191]191 Subclass 191 indent level is 2 Aluminum (including salts)
[List of Pre Grant Publications for class 514 subclass 192][List of Patents for class 514 subclass 192]192 Subclass 192 indent level is 2 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.)
[List of Pre Grant Publications for class 514 subclass 200][List of Patents for class 514 subclass 200]200 Subclass 200 indent level is 2 1-thia-5-aza-bicyclo (4.2.0) octane ring containing (including dehydrogenated) (e.g., cephalosporins, etc.)
[List of Pre Grant Publications for class 514 subclass 210.01][List of Patents for class 514 subclass 210.01]210.01 Subclass 210.01 indent level is 2 Hetero ring is four-membered and includes at least one ring nitrogen
[List of Pre Grant Publications for class 514 subclass 210.02][List of Patents for class 514 subclass 210.02]210.02 Subclass 210.02 indent level is 3 Chalcogen double bonded directly to a ring carbon of the four-membered hetero ring which is adjacent to the ring nitrogen
 [List of Pre Grant Publications for class 514 subclass 210.16][List of Patents for class 514 subclass 210.16]210.16 Subclass 210.16 indent level is 3 Polycyclo ring system having the four-membered hetero ring as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 210.17][List of Patents for class 514 subclass 210.17]210.17 Subclass 210.17 indent level is 3 Having -C(=X)-, wherein X is chalcogen, bonded directly to the four-membered hetero ring
[List of Pre Grant Publications for class 514 subclass 210.19][List of Patents for class 514 subclass 210.19]210.19 Subclass 210.19 indent level is 3 Additional hetero ring attached directly or indirectly to the four-membered hetero ring by nonionic bonding
[List of Pre Grant Publications for class 514 subclass 211.01][List of Patents for class 514 subclass 211.01]211.01 Subclass 211.01 indent level is 2 Hetero ring contains seven members including nitrogen, carbon and chalcogen
[List of Pre Grant Publications for class 514 subclass 212.01][List of Patents for class 514 subclass 212.01]212.01 Subclass 212.01 indent level is 2 Hetero ring is seven-membered consisting of one nitrogen and six carbons
 [List of Pre Grant Publications for class 514 subclass 212.02][List of Patents for class 514 subclass 212.02]212.02 Subclass 212.02 indent level is 3 Spiro
[List of Pre Grant Publications for class 514 subclass 212.03][List of Patents for class 514 subclass 212.03]212.03 Subclass 212.03 indent level is 3 Chalcogen double bonded directly to a ring carbon of the seven-membered hetero ring which is adjacent to the ring nitrogen
[List of Pre Grant Publications for class 514 subclass 213.01][List of Patents for class 514 subclass 213.01]213.01 Subclass 213.01 indent level is 3 Polycyclo ring system having the seven-membered hetero ring as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 217.03][List of Patents for class 514 subclass 217.03]217.03 Subclass 217.03 indent level is 3 Additional hetero ring attached directly or indirectly to the seven-membered hetero ring by nonionic bonding
 [List of Pre Grant Publications for class 514 subclass 217.11][List of Patents for class 514 subclass 217.11]217.11 Subclass 217.11 indent level is 3 Nitrogen or C(=X), wherein X is chalcogen, bonded directly to the seven-membered hetero ring
 [List of Pre Grant Publications for class 514 subclass 217.12][List of Patents for class 514 subclass 217.12]217.12 Subclass 217.12 indent level is 3 Nitrogen or C(=X), wherein X is chalcogen, attached indirectly to the seven-membered hetero ring by acyclic nonionic bonding
[List of Pre Grant Publications for class 514 subclass 218][List of Patents for class 514 subclass 218]218 Subclass 218 indent level is 2 Hetero ring is seven-membered consisting of two nitrogens and five carbon atoms
[List of Pre Grant Publications for class 514 subclass 222.2][List of Patents for class 514 subclass 222.2]222.2 Subclass 222.2 indent level is 2 Hetero ring is six-membered and includes at least nitrogen and sulfur as ring members
[List of Pre Grant Publications for class 514 subclass 228.8][List of Patents for class 514 subclass 228.8]228.8 Subclass 228.8 indent level is 2 Hetero ring is six-membered and includes at least nitrogen and oxygen as ring hetero atoms (e.g., monocyclic 1,2- and 1,3-oxazines, etc.)
 [List of Pre Grant Publications for class 514 subclass 229.2][List of Patents for class 514 subclass 229.2]229.2 Subclass 229.2 indent level is 3 Three or more ring hetero atoms in the six-membered hetero ring
[List of Pre Grant Publications for class 514 subclass 229.5][List of Patents for class 514 subclass 229.5]229.5 Subclass 229.5 indent level is 3 Polycyclo ring system having the six-membered hetero ring as one of the cyclos (e.g., maytansinoids, etc.)
 [List of Pre Grant Publications for class 514 subclass 230.8][List of Patents for class 514 subclass 230.8]230.8 Subclass 230.8 indent level is 3 Chalcogen bonded directly to ring carbon of 1,4-oxazine ring
[List of Pre Grant Publications for class 514 subclass 231.2][List of Patents for class 514 subclass 231.2]231.2 Subclass 231.2 indent level is 3 Morpholines (i.e., fully hydrogenated 1,4- oxazines)
[List of Pre Grant Publications for class 514 subclass 231.5][List of Patents for class 514 subclass 231.5]231.5 Subclass 231.5 indent level is 4 Additional hetero ring attached directly or indirectly to the morpholine ring by nonionic bonding
 [List of Pre Grant Publications for class 514 subclass 237.5][List of Patents for class 514 subclass 237.5]237.5 Subclass 237.5 indent level is 4 Having -C(=X)-, wherein X is chalcogen, bonded directly to the morpholine ring
[List of Pre Grant Publications for class 514 subclass 237.8][List of Patents for class 514 subclass 237.8]237.8 Subclass 237.8 indent level is 4 Nitrogen attached indirectly to the morpholine ring by acyclic nonionic bonding
[List of Pre Grant Publications for class 514 subclass 238.8][List of Patents for class 514 subclass 238.8]238.8 Subclass 238.8 indent level is 4 Chalcogen attached indirectly to the morpholine ring by acyclic nonionic bonding
 [List of Pre Grant Publications for class 514 subclass 239.5][List of Patents for class 514 subclass 239.5]239.5 Subclass 239.5 indent level is 4 Carbocyclic ring attached indirectly to the morpholine ring by nonionic bonding
[List of Pre Grant Publications for class 514 subclass 241][List of Patents for class 514 subclass 241]241 Subclass 241 indent level is 2 Hetero ring is six-membered consisting of three nitrogens and three carbon atoms
[List of Pre Grant Publications for class 514 subclass 247][List of Patents for class 514 subclass 247]247 Subclass 247 indent level is 2 Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.)
[List of Pre Grant Publications for class 514 subclass 248][List of Patents for class 514 subclass 248]248 Subclass 248 indent level is 3 Polycyclo ring system having a 1,2- or 1,4-diazine as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 252.01][List of Patents for class 514 subclass 252.01]252.01 Subclass 252.01 indent level is 3 1,2 diazine attached directly or indirectly to an additional hetero ring by nonionic bonding
[List of Pre Grant Publications for class 514 subclass 252.1][List of Patents for class 514 subclass 252.1]252.1 Subclass 252.1 indent level is 3 1,4 diazines
 [List of Pre Grant Publications for class 514 subclass 252.11][List of Patents for class 514 subclass 252.11]252.11 Subclass 252.11 indent level is 4 Plural 1,4-diazine rings attached directly or indirectly to each other by nonionic bonding
[List of Pre Grant Publications for class 514 subclass 252.12][List of Patents for class 514 subclass 252.12]252.12 Subclass 252.12 indent level is 4 Piperazines (i.e., fully hydrogenated 1,4-diazines)
[List of Pre Grant Publications for class 514 subclass 252.13][List of Patents for class 514 subclass 252.13]252.13 Subclass 252.13 indent level is 5 Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding
[List of Pre Grant Publications for class 514 subclass 252.14][List of Patents for class 514 subclass 252.14]252.14 Subclass 252.14 indent level is 6 The additional hetero ring is a 1,3 diazine ring
[List of Pre Grant Publications for class 514 subclass 253.01][List of Patents for class 514 subclass 253.01]253.01 Subclass 253.01 indent level is 6 The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms
[List of Pre Grant Publications for class 514 subclass 254.01][List of Patents for class 514 subclass 254.01]254.01 Subclass 254.01 indent level is 6 The additional hetero ring is five-membered having ring nitrogen
[List of Pre Grant Publications for class 514 subclass 254.1][List of Patents for class 514 subclass 254.1]254.1 Subclass 254.1 indent level is 6 Ring oxygen in the additional hetero ring
 [List of Pre Grant Publications for class 514 subclass 255.01][List of Patents for class 514 subclass 255.01]255.01 Subclass 255.01 indent level is 5 Nitrogen or -C(=X)-, wherein X is chalcogen, bonded directly to the piperazine ring
 [List of Pre Grant Publications for class 514 subclass 255.02][List of Patents for class 514 subclass 255.02]255.02 Subclass 255.02 indent level is 5 Chalcogen bonded directly to a piperazine ring carbon
 [List of Pre Grant Publications for class 514 subclass 255.03][List of Patents for class 514 subclass 255.03]255.03 Subclass 255.03 indent level is 5 Carbocyclic ring bonded directly to the piperazine ring
 [List of Pre Grant Publications for class 514 subclass 255.04][List of Patents for class 514 subclass 255.04]255.04 Subclass 255.04 indent level is 5 Plural carbocyclic rings bonded directly to the same acyclic carbon atom which is attached directly or indirectly to the piperazine ring by nonionic bonding
 [List of Pre Grant Publications for class 514 subclass 255.05][List of Patents for class 514 subclass 255.05]255.05 Subclass 255.05 indent level is 4 Additional hetero ring attached directly or indirectly to the 1,4-diazine ring by nonionic bonding
 [List of Pre Grant Publications for class 514 subclass 255.06][List of Patents for class 514 subclass 255.06]255.06 Subclass 255.06 indent level is 4 Nitrogen or -C(=X)-, wherein X is chalcogen, bonded directly to ring carbon of the 1,4-diazine ring
[List of Pre Grant Publications for class 514 subclass 256][List of Patents for class 514 subclass 256]256 Subclass 256 indent level is 3 1,3-diazines (e.g., pyrimidines, etc.)
[List of Pre Grant Publications for class 514 subclass 257][List of Patents for class 514 subclass 257]257 Subclass 257 indent level is 4 Polycyclo ring system having 1,3-diazine as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 258.1][List of Patents for class 514 subclass 258.1]258.1 Subclass 258.1 indent level is 5 Bicyclo ring system having the 1,3-diazine as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 259.1][List of Patents for class 514 subclass 259.1]259.1 Subclass 259.1 indent level is 6 A ring nitrogen is shared by the two cyclos of the bicyclo ring system (e.g., pyrrolo [1,2-a]pyrimidine, imidazo[1,2-a]pyrimidine, etc.)
 [List of Pre Grant Publications for class 514 subclass 260.1][List of Patents for class 514 subclass 260.1]260.1 Subclass 260.1 indent level is 6 Ring chalcogen in the bicyclo ring system
 [List of Pre Grant Publications for class 514 subclass 261.1][List of Patents for class 514 subclass 261.1]261.1 Subclass 261.1 indent level is 6 Exactly five ring nitrogens in the bicyclo ring system (e.g., triazolo[4,5-d]pyrimidine, etc.)
[List of Pre Grant Publications for class 514 subclass 262.1][List of Patents for class 514 subclass 262.1]262.1 Subclass 262.1 indent level is 6 Exactly four ring nitrogens in the bicyclo ring system
[List of Pre Grant Publications for class 514 subclass 264.1][List of Patents for class 514 subclass 264.1]264.1 Subclass 264.1 indent level is 6 The other cyclo in the bicyclo ring system is a pyridine ring (including hydrogenated) (e.g., pyrido[2,3-d]pyrimidine, etc.)
 [List of Pre Grant Publications for class 514 subclass 265.1][List of Patents for class 514 subclass 265.1]265.1 Subclass 265.1 indent level is 6 The other cyclo in the bicyclo ring system is a pyrrole ring (including hydrogenated) (e.g., pyrrolo[3,2-d]pyrimidine, etc.)
[List of Pre Grant Publications for class 514 subclass 266.1][List of Patents for class 514 subclass 266.1]266.1 Subclass 266.1 indent level is 6 Quinazoline (including hydrogenated)(i.e., the second cyclo in the bicyclo ring system is an ortho-fused six-membered carbocycle)
[List of Pre Grant Publications for class 514 subclass 267][List of Patents for class 514 subclass 267]267 Subclass 267 indent level is 5 Tricyclo ring system having 1,3-diazine as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 269][List of Patents for class 514 subclass 269]269 Subclass 269 indent level is 4 Pyrimidines with chalcogen bonded directly to a ring carbon of said pyrimidine moiety
 [List of Pre Grant Publications for class 514 subclass 275][List of Patents for class 514 subclass 275]275 Subclass 275 indent level is 4 Nitrogen bonded directly to the 1,3-diazine at 2-position by a single bond
 [List of Pre Grant Publications for class 514 subclass 276][List of Patents for class 514 subclass 276]276 Subclass 276 indent level is 4 Thiamines (e.g., vitamin B1, etc.)
[List of Pre Grant Publications for class 514 subclass 277][List of Patents for class 514 subclass 277]277 Subclass 277 indent level is 2 Hetero ring is six-membered consisting of one nitrogen and five carbon atoms
 [List of Pre Grant Publications for class 514 subclass 278][List of Patents for class 514 subclass 278]278 Subclass 278 indent level is 3 Spiro ring system
[List of Pre Grant Publications for class 514 subclass 279][List of Patents for class 514 subclass 279]279 Subclass 279 indent level is 3 Polycyclo ring system having the six-membered hetero ring as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 280][List of Patents for class 514 subclass 280]280 Subclass 280 indent level is 4 Pentacyclo ring system having the six-membered hetero ring as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 284][List of Patents for class 514 subclass 284]284 Subclass 284 indent level is 4 Tetracyclo ring system having the six-membered hetero ring as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 290][List of Patents for class 514 subclass 290]290 Subclass 290 indent level is 4 Tricyclo ring system having the six-membered hetero ring as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 299][List of Patents for class 514 subclass 299]299 Subclass 299 indent level is 4 Bicyclo ring system having the six-membered hetero ring as one of the cyclos
[List of Pre Grant Publications for class 514 subclass 315][List of Patents for class 514 subclass 315]315 Subclass 315 indent level is 3 Piperidines
[List of Pre Grant Publications for class 514 subclass 332][List of Patents for class 514 subclass 332]332 Subclass 332 indent level is 3 Plural six-membered hetero rings consisting of one nitrogen and five carbon atoms
[List of Pre Grant Publications for class 514 subclass 336][List of Patents for class 514 subclass 336]336 Subclass 336 indent level is 3 Additional hetero ring containing
 [List of Pre Grant Publications for class 514 subclass 344][List of Patents for class 514 subclass 344]344 Subclass 344 indent level is 3 Cyano bonded directly to the six-membered hetero ring
[List of Pre Grant Publications for class 514 subclass 345][List of Patents for class 514 subclass 345]345 Subclass 345 indent level is 3 Chalcogen bonded directly to ring carbon of the six-membered hetero ring
[List of Pre Grant Publications for class 514 subclass 352][List of Patents for class 514 subclass 352]352 Subclass 352 indent level is 3 Nitrogen attached directly to the six-membered hetero ring by nonionic bonding
[List of Pre Grant Publications for class 514 subclass 354][List of Patents for class 514 subclass 354]354 Subclass 354 indent level is 3 C=O bonded directly to the six-membered hetero ring
 [List of Pre Grant Publications for class 514 subclass 357][List of Patents for class 514 subclass 357]357 Subclass 357 indent level is 3 Nitrogen attached indirectly to the six-membered hetero ring by nonionic bonding
 [List of Pre Grant Publications for class 514 subclass 358][List of Patents for class 514 subclass 358]358 Subclass 358 indent level is 3 The ring nitrogen of the six-membered hetero ring is pentavalent (e.g., quaternary pyridinium salt, etc.)
[List of Pre Grant Publications for class 514 subclass 359][List of Patents for class 514 subclass 359]359 Subclass 359 indent level is 2 Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.)
 [List of Pre Grant Publications for class 514 subclass 360][List of Patents for class 514 subclass 360]360 Subclass 360 indent level is 3 Plural ring chalcogens in the hetero ring
[List of Pre Grant Publications for class 514 subclass 361][List of Patents for class 514 subclass 361]361 Subclass 361 indent level is 3 Plural ring nitrogens and a single chalcogen in the hetero ring
[List of Pre Grant Publications for class 514 subclass 365][List of Patents for class 514 subclass 365]365 Subclass 365 indent level is 3 1,3-thiazoles (including hydrogenated)
[List of Pre Grant Publications for class 514 subclass 372][List of Patents for class 514 subclass 372]372 Subclass 372 indent level is 3 1,2-thiazoles (including hydrogenated)
[List of Pre Grant Publications for class 514 subclass 374][List of Patents for class 514 subclass 374]374 Subclass 374 indent level is 3 1,3-oxazoles (including hydrogenated)
[List of Pre Grant Publications for class 514 subclass 378][List of Patents for class 514 subclass 378]378 Subclass 378 indent level is 3 1,2-oxazoles (including hydrogenated)
[List of Pre Grant Publications for class 514 subclass 381][List of Patents for class 514 subclass 381]381 Subclass 381 indent level is 3 Tetrazoles (including hydrogenated)
[List of Pre Grant Publications for class 514 subclass 383][List of Patents for class 514 subclass 383]383 Subclass 383 indent level is 3 1,2,4-triazoles (including hydrogenated)
[List of Pre Grant Publications for class 514 subclass 385][List of Patents for class 514 subclass 385]385 Subclass 385 indent level is 3 1,3-diazoles
[List of Pre Grant Publications for class 514 subclass 403][List of Patents for class 514 subclass 403]403 Subclass 403 indent level is 3 1,2-diazoles
[List of Pre Grant Publications for class 514 subclass 408][List of Patents for class 514 subclass 408]408 Subclass 408 indent level is 3 The five-membered hetero ring consists of one nitrogen and four carbons
 [List of Pre Grant Publications for class 514 subclass 409][List of Patents for class 514 subclass 409]409 Subclass 409 indent level is 4 Spiro ring system
[List of Pre Grant Publications for class 514 subclass 410][List of Patents for class 514 subclass 410]410 Subclass 410 indent level is 4 Polycyclo ring system having the five-membered hetero ring as one of the cyclos
 [List of Pre Grant Publications for class 514 subclass 422][List of Patents for class 514 subclass 422]422 Subclass 422 indent level is 4 Additional hetero ring
 [List of Pre Grant Publications for class 514 subclass 423][List of Patents for class 514 subclass 423]423 Subclass 423 indent level is 4 C=X bonded directly to the five-membered hetero ring by nonionic bonding (X is chalcogen)
[List of Pre Grant Publications for class 514 subclass 424][List of Patents for class 514 subclass 424]424 Subclass 424 indent level is 4 Chalcogen bonded directly to the five-membered hetero ring by nonionic bonding
 [List of Pre Grant Publications for class 514 subclass 426][List of Patents for class 514 subclass 426]426 Subclass 426 indent level is 4 Nitrogen bonded directly to the five-membered hetero ring by nonionic bonding
 [List of Pre Grant Publications for class 514 subclass 427][List of Patents for class 514 subclass 427]427 Subclass 427 indent level is 4 Two double bonds between ring members of the five-membered hetero ring (e.g., pyrrole, etc.)
 [List of Pre Grant Publications for class 514 subclass 428][List of Patents for class 514 subclass 428]428 Subclass 428 indent level is 4 Chalcogen bonded indirectly to the five-membered hetero ring by acyclic nonionic bonding
 [List of Pre Grant Publications for class 514 subclass 429][List of Patents for class 514 subclass 429]429 Subclass 429 indent level is 4 Carbocyclic ring bonded directly to the five-membered hetero ring
[List of Pre Grant Publications for class 514 subclass 430][List of Patents for class 514 subclass 430]430 Subclass 430 indent level is 2 Sulfur containing hetero ring
[List of Pre Grant Publications for class 514 subclass 449][List of Patents for class 514 subclass 449]449 Subclass 449 indent level is 2 Oxygen containing hetero ring
[List of Pre Grant Publications for class 514 subclass 476][List of Patents for class 514 subclass 476]476 Subclass 476 indent level is 1 N-C(=X)X containing (X is chalcogen) DOAI
[List of Pre Grant Publications for class 514 subclass 492][List of Patents for class 514 subclass 492]492 Subclass 492 indent level is 1 Heavy metal containing DOAI
[List of Pre Grant Publications for class 514 subclass 506][List of Patents for class 514 subclass 506]506 Subclass 506 indent level is 1 Ester DOAI
 [List of Pre Grant Publications for class 514 subclass 507][List of Patents for class 514 subclass 507]507 Subclass 507 indent level is 2 R-C(=X)-N-X-C containing (e.g., hydroxamic acid ester, etc.) (R is C or H and X is chalcogen)
 [List of Pre Grant Publications for class 514 subclass 508][List of Patents for class 514 subclass 508]508 Subclass 508 indent level is 2 X-C=N containing (e.g., imidoester, etc.) (X is chalcogen)
 [List of Pre Grant Publications for class 514 subclass 509][List of Patents for class 514 subclass 509]509 Subclass 509 indent level is 2 (O=)N(=O)-O-C containing (e.g., nitrate ester, etc.)
[List of Pre Grant Publications for class 514 subclass 510][List of Patents for class 514 subclass 510]510 Subclass 510 indent level is 2 Polycyclo ring system
 [List of Pre Grant Publications for class 514 subclass 512][List of Patents for class 514 subclass 512]512 Subclass 512 indent level is 2 X-C(=X)-X containing (e.g., carbonic acid ester, thiocarbonic acid ester, etc.) (X is chalcogen)
 [List of Pre Grant Publications for class 514 subclass 513][List of Patents for class 514 subclass 513]513 Subclass 513 indent level is 2 C-C(=X)-X-C containing (X is chalcogen and at least one X is other than oxygen)
[List of Pre Grant Publications for class 514 subclass 514][List of Patents for class 514 subclass 514]514 Subclass 514 indent level is 2 Carbon bonded to -NCX or -XCN (e.g., cyanate, thiocyanate or isothiocyanate, etc.) (X is chalcogen)
[List of Pre Grant Publications for class 514 subclass 517][List of Patents for class 514 subclass 517]517 Subclass 517 indent level is 2 S-X-C containing (e.g., sulfates, etc.) (X is chalcogen)
[List of Pre Grant Publications for class 514 subclass 519][List of Patents for class 514 subclass 519]519 Subclass 519 indent level is 2 Cyano or isocyano bonded directly to carbon
[List of Pre Grant Publications for class 514 subclass 529][List of Patents for class 514 subclass 529]529 Subclass 529 indent level is 2 Z-C(=O)-O-Y wherein Z is hydrogen or an organic radical bonded to the C(=O) by a carbon and Y is an organic radical bonded to the oxygen by a carbon
[List of Pre Grant Publications for class 514 subclass 553][List of Patents for class 514 subclass 553]553 Subclass 553 indent level is 1 Radical -XH acid, or anhydride, acid halide or salt thereof (X is chalcogen) DOAI
[List of Pre Grant Publications for class 514 subclass 579][List of Patents for class 514 subclass 579]579 Subclass 579 indent level is 1 Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI
[List of Pre Grant Publications for class 514 subclass 580][List of Patents for class 514 subclass 580]580 Subclass 580 indent level is 2 Thioureas (i.e., N-C(=S)-N
[List of Pre Grant Publications for class 514 subclass 588][List of Patents for class 514 subclass 588]588 Subclass 588 indent level is 2 Ureas (i.e., N-C(=O)-N)
 [List of Pre Grant Publications for class 514 subclass 599][List of Patents for class 514 subclass 599]599 Subclass 599 indent level is 2 Thiocarboxamides, (i.e., C(=S)-N)
 [List of Pre Grant Publications for class 514 subclass 600][List of Patents for class 514 subclass 600]600 Subclass 600 indent level is 2 Sulfamides (i.e., N-(O=)S(=O)-N)
[List of Pre Grant Publications for class 514 subclass 601][List of Patents for class 514 subclass 601]601 Subclass 601 indent level is 2 Sulfonamides (i.e., Q-(O=)S(=O)-N, wherein Q is a substituent and wherein any substituent attached to the nitrogen will be referred to as E)
 [List of Pre Grant Publications for class 514 subclass 606][List of Patents for class 514 subclass 606]606 Subclass 606 indent level is 2 N-S-S containing
 [List of Pre Grant Publications for class 514 subclass 607][List of Patents for class 514 subclass 607]607 Subclass 607 indent level is 2 N-S-N containing or contains a nitrogen bonded directly to a S=O group (e.g., sulfinamides, etc.)
 [List of Pre Grant Publications for class 514 subclass 608][List of Patents for class 514 subclass 608]608 Subclass 608 indent level is 2 Sulfur attached directly to amino nitrogen by nonionic bonding (e.g., sulfenamides, etc.)
 [List of Pre Grant Publications for class 514 subclass 609][List of Patents for class 514 subclass 609]609 Subclass 609 indent level is 2 Cyanamides (i.e., compounds containing cyano bonded directly to amino nitrogen)
 [List of Pre Grant Publications for class 514 subclass 610][List of Patents for class 514 subclass 610]610 Subclass 610 indent level is 2 Nitramines (i.e., compounds containing nitro bonded directly to amino nitrogen)
 [List of Pre Grant Publications for class 514 subclass 611][List of Patents for class 514 subclass 611]611 Subclass 611 indent level is 2 Nitrosamines (i.e., compounds containing nitroso bonded directly to amino nitrogen)
 [List of Pre Grant Publications for class 514 subclass 612][List of Patents for class 514 subclass 612]612 Subclass 612 indent level is 2 Haloamines (i.e., compounds containing halogen attached directly to amino nitrogen by nonionic bonding)
[List of Pre Grant Publications for class 514 subclass 613][List of Patents for class 514 subclass 613]613 Subclass 613 indent level is 2 Carboxamides (i.e., R-C(=O)-N, wherein R is a radical having carbon bonded directly to the C(=O)-N or is hydrogen and wherein any substituent attached to nitrogen will be referred to as E)
[List of Pre Grant Publications for class 514 subclass 631][List of Patents for class 514 subclass 631]631 Subclass 631 indent level is 2 Amidines (i.e., N=C-N)
[List of Pre Grant Publications for class 514 subclass 638][List of Patents for class 514 subclass 638]638 Subclass 638 indent level is 2 Nitrogen double bonded directly to carbon
[List of Pre Grant Publications for class 514 subclass 642][List of Patents for class 514 subclass 642]642 Subclass 642 indent level is 2 Quaternary ammonium containing
 [List of Pre Grant Publications for class 514 subclass 644][List of Patents for class 514 subclass 644]644 Subclass 644 indent level is 2 Amine oxides
 [List of Pre Grant Publications for class 514 subclass 645][List of Patents for class 514 subclass 645]645 Subclass 645 indent level is 2 Nitroxides, oxyamines or hydroxylamines (i.e., N-O or N-OH)
[List of Pre Grant Publications for class 514 subclass 646][List of Patents for class 514 subclass 646]646 Subclass 646 indent level is 2 Benzene ring containing
 [List of Pre Grant Publications for class 514 subclass 659][List of Patents for class 514 subclass 659]659 Subclass 659 indent level is 2 Alicyclic ring or ring system and amino nitrogen are attached indirectly by an acyclic carbon or acyclic chain
[List of Pre Grant Publications for class 514 subclass 660][List of Patents for class 514 subclass 660]660 Subclass 660 indent level is 2 Plural alicyclic rings
[List of Pre Grant Publications for class 514 subclass 663][List of Patents for class 514 subclass 663]663 Subclass 663 indent level is 2 Acyclic
[List of Pre Grant Publications for class 514 subclass 675][List of Patents for class 514 subclass 675]675 Subclass 675 indent level is 1 Ketone DOAI
[List of Pre Grant Publications for class 514 subclass 693][List of Patents for class 514 subclass 693]693 Subclass 693 indent level is 1 Aldehyde DOAI
[List of Pre Grant Publications for class 514 subclass 706][List of Patents for class 514 subclass 706]706 Subclass 706 indent level is 1 Sulfur, selenium or tellurium compound (e.g., thioalcohols, mercaptans, etc.)
 [List of Pre Grant Publications for class 514 subclass 714][List of Patents for class 514 subclass 714]714 Subclass 714 indent level is 1 Peroxide DOAI
[List of Pre Grant Publications for class 514 subclass 715][List of Patents for class 514 subclass 715]715 Subclass 715 indent level is 1 Ether DOAI
[List of Pre Grant Publications for class 514 subclass 724][List of Patents for class 514 subclass 724]724 Subclass 724 indent level is 1 C-O-group (e.g., alcohol, alcoholate, etc.) DOAI
[List of Pre Grant Publications for class 514 subclass 740][List of Patents for class 514 subclass 740]740 Subclass 740 indent level is 1 Nitrogen containing compound DOAI
[List of Pre Grant Publications for class 514 subclass 743][List of Patents for class 514 subclass 743]743 Subclass 743 indent level is 1 Halogenated hydrocarbon DOAI
[List of Pre Grant Publications for class 514 subclass 762][List of Patents for class 514 subclass 762]762 Subclass 762 indent level is 1 Hydrocarbon DOAI
[List of Pre Grant Publications for class 514 subclass 769][List of Patents for class 514 subclass 769]769 DESIGNATED INORGANIC NONACTIVE INGREDIENT OR ELEMENTAL MATERIAL OTHER THAN WATER
[List of Pre Grant Publications for class 514 subclass 772][List of Patents for class 514 subclass 772]772 DESIGNATED ORGANIC NONACTIVE INGREDIENT CONTAINING OTHER THAN HYDROCARBON
 [List of Pre Grant Publications for class 514 subclass 788.1][List of Patents for class 514 subclass 788.1]788.1 SOLID SYNTHETIC ORGANIC POLYMER DERIVED SOLELY FROM HYDROCARBON REACTANTS AS DESIGNATED ORGANIC NONACTIVE INGREDIENT CONTAINING
 [List of Pre Grant Publications for class 514 subclass 789][List of Patents for class 514 subclass 789]789 MISCELLANEOUS (E.G., HYDROCARBONS, ETC.)
 
CROSS-REFERENCE ART COLLECTIONS
 
 [List of Pre Grant Publications for class 514 subclass 800][List of Patents for class 514 subclass 800]800 LHRH LIKE
 [List of Pre Grant Publications for class 514 subclass 801][List of Patents for class 514 subclass 801]801 COLLAGEN, GELATIN OR DERIVATIVES THEREOF
 [List of Pre Grant Publications for class 514 subclass 802][List of Patents for class 514 subclass 802]802 FIBRINOPEPTIDES, BLOOD-COAGULATION FACTORS OR DERIVATIVES
 [List of Pre Grant Publications for class 514 subclass 803][List of Patents for class 514 subclass 803]803 KININ OR DERIVATIVES
 [List of Pre Grant Publications for class 514 subclass 804][List of Patents for class 514 subclass 804]804 PHECMYCIN SERIES OR DERIVATIVES
 [List of Pre Grant Publications for class 514 subclass 805][List of Patents for class 514 subclass 805]805 ADRENOCORTICOTROPIC HORMONE OR DERIVATIVES
 [List of Pre Grant Publications for class 514 subclass 806][List of Patents for class 514 subclass 806]806 SOMATOSTATIN OR DERIVATIVES
 [List of Pre Grant Publications for class 514 subclass 807][List of Patents for class 514 subclass 807]807 OXYTOXIN, VASOPRESSIN OR DERIVATIVES
 [List of Pre Grant Publications for class 514 subclass 808][List of Patents for class 514 subclass 808]808 CALCITONIN OR DERIVATIVES
 [List of Pre Grant Publications for class 514 subclass 809][List of Patents for class 514 subclass 809]809 ENKEPHALIN OR ENDORPHIN OR DERIVATIVES
[List of Pre Grant Publications for class 514 subclass 810][List of Patents for class 514 subclass 810]810 ADDICTION
[List of Pre Grant Publications for class 514 subclass 814][List of Patents for class 514 subclass 814]814 ANEMIA
 [List of Pre Grant Publications for class 514 subclass 816][List of Patents for class 514 subclass 816]816 ANESTHETIC, GENERAL
 [List of Pre Grant Publications for class 514 subclass 817][List of Patents for class 514 subclass 817]817 ANESTHETIC, TOPICAL
 [List of Pre Grant Publications for class 514 subclass 818][List of Patents for class 514 subclass 818]818 ANESTHETIC, LOCAL
[List of Pre Grant Publications for class 514 subclass 819][List of Patents for class 514 subclass 819]819 ANTACID, ORAL
 [List of Pre Grant Publications for class 514 subclass 821][List of Patents for class 514 subclass 821]821 ANTIARRHYTHMIC
 [List of Pre Grant Publications for class 514 subclass 822][List of Patents for class 514 subclass 822]822 ANTICOAGULATION
 [List of Pre Grant Publications for class 514 subclass 823][List of Patents for class 514 subclass 823]823 ANTIDOTE
 [List of Pre Grant Publications for class 514 subclass 824][List of Patents for class 514 subclass 824]824 ARTERIOSCLEROSIS
 [List of Pre Grant Publications for class 514 subclass 825][List of Patents for class 514 subclass 825]825 ARTHRITIS
 [List of Pre Grant Publications for class 514 subclass 826][List of Patents for class 514 subclass 826]826 ASTHMA
[List of Pre Grant Publications for class 514 subclass 827][List of Patents for class 514 subclass 827]827 ASTRINGENT, NONFACIAL
[List of Pre Grant Publications for class 514 subclass 829][List of Patents for class 514 subclass 829]829 BITE OR STING
 [List of Pre Grant Publications for class 514 subclass 832][List of Patents for class 514 subclass 832]832 BLOOD SUBSTITUTE
 [List of Pre Grant Publications for class 514 subclass 833][List of Patents for class 514 subclass 833]833 BLOOD PLASMA EXTENDER
 [List of Pre Grant Publications for class 514 subclass 834][List of Patents for class 514 subclass 834]834 COAGULANT
 [List of Pre Grant Publications for class 514 subclass 835][List of Patents for class 514 subclass 835]835 CARIES
 [List of Pre Grant Publications for class 514 subclass 836][List of Patents for class 514 subclass 836]836 CHELATE
 [List of Pre Grant Publications for class 514 subclass 837][List of Patents for class 514 subclass 837]837 CHOLERA
 [List of Pre Grant Publications for class 514 subclass 838][List of Patents for class 514 subclass 838]838 CIRRHOSIS
[List of Pre Grant Publications for class 514 subclass 839][List of Patents for class 514 subclass 839]839 CONTACT LENS TREATMENT
[List of Pre Grant Publications for class 514 subclass 841][List of Patents for class 514 subclass 841]841 CONTRACEPTIVE
[List of Pre Grant Publications for class 514 subclass 844][List of Patents for class 514 subclass 844]844 COSMETIC, FACIAL
[List of Pre Grant Publications for class 514 subclass 849][List of Patents for class 514 subclass 849]849 COUGH AND COLD PREPARATION
 [List of Pre Grant Publications for class 514 subclass 851][List of Patents for class 514 subclass 851]851 CYSTIC FIBROSIS
 [List of Pre Grant Publications for class 514 subclass 852][List of Patents for class 514 subclass 852]852 DANDRUFF
[List of Pre Grant Publications for class 514 subclass 853][List of Patents for class 514 subclass 853]853 DECONGESTANT
     DERMATITIS
 [List of Pre Grant Publications for class 514 subclass 866][List of Patents for class 514 subclass 866]866 DIABETES
 [List of Pre Grant Publications for class 514 subclass 867][List of Patents for class 514 subclass 867]867 DIARRHEA
 [List of Pre Grant Publications for class 514 subclass 868][List of Patents for class 514 subclass 868]868 DISTEMPER
 [List of Pre Grant Publications for class 514 subclass 869][List of Patents for class 514 subclass 869]869 DIURETIC
[List of Pre Grant Publications for class 514 subclass 870][List of Patents for class 514 subclass 870]870 EDEMA
 [List of Pre Grant Publications for class 514 subclass 872][List of Patents for class 514 subclass 872]872 EMESIS (MOTION SICKNESS-NAUSEA)
 [List of Pre Grant Publications for class 514 subclass 873][List of Patents for class 514 subclass 873]873 EMOLLIENT
 [List of Pre Grant Publications for class 514 subclass 874][List of Patents for class 514 subclass 874]874 ESTROGENIC AGENT (NONCONTRACEPTIVE)
[List of Pre Grant Publications for class 514 subclass 875][List of Patents for class 514 subclass 875]875 FLEA CONTROL
 [List of Pre Grant Publications for class 514 subclass 877][List of Patents for class 514 subclass 877]877 GALLSTONE
[List of Pre Grant Publications for class 514 subclass 878][List of Patents for class 514 subclass 878]878 GERIATRICS
[List of Pre Grant Publications for class 514 subclass 880][List of Patents for class 514 subclass 880]880 HAIR TREATMENT (THERAPEUTIC-SCALP)
 [List of Pre Grant Publications for class 514 subclass 882][List of Patents for class 514 subclass 882]882 HEMORRHOID PREPARATION
 [List of Pre Grant Publications for class 514 subclass 883][List of Patents for class 514 subclass 883]883 HODGKIN'S DISEASE
 [List of Pre Grant Publications for class 514 subclass 884][List of Patents for class 514 subclass 884]884 HYPOGLYCEMIA
 [List of Pre Grant Publications for class 514 subclass 885][List of Patents for class 514 subclass 885]885 IMMUNE RESPONSE AFFECTING DRUG
[List of Pre Grant Publications for class 514 subclass 886][List of Patents for class 514 subclass 886]886 INFLAMMATION, SKIN
 [List of Pre Grant Publications for class 514 subclass 888][List of Patents for class 514 subclass 888]888 INFLUENZA
 [List of Pre Grant Publications for class 514 subclass 889][List of Patents for class 514 subclass 889]889 INTERFERON INDUCER
 [List of Pre Grant Publications for class 514 subclass 890][List of Patents for class 514 subclass 890]890 IRRITANT (E.G., TEAR GAS, ETC.)
 [List of Pre Grant Publications for class 514 subclass 891][List of Patents for class 514 subclass 891]891 KIDNEY STONE
 [List of Pre Grant Publications for class 514 subclass 892][List of Patents for class 514 subclass 892]892 LAXATIVE
[List of Pre Grant Publications for class 514 subclass 893][List of Patents for class 514 subclass 893]893 LIVER DISORDER
 [List of Pre Grant Publications for class 514 subclass 895][List of Patents for class 514 subclass 895]895 MALARIA
[List of Pre Grant Publications for class 514 subclass 896][List of Patents for class 514 subclass 896]896 MEASLES
 [List of Pre Grant Publications for class 514 subclass 898][List of Patents for class 514 subclass 898]898 MENINGITIS
 [List of Pre Grant Publications for class 514 subclass 899][List of Patents for class 514 subclass 899]899 MENSTRUAL DISORDER
     MOUTH TREATMENT
 [List of Pre Grant Publications for class 514 subclass 903][List of Patents for class 514 subclass 903]903 MULTIPLE SCLEROSIS
[List of Pre Grant Publications for class 514 subclass 904][List of Patents for class 514 subclass 904]904 MULTIPLE VITAMINS
 [List of Pre Grant Publications for class 514 subclass 906][List of Patents for class 514 subclass 906]906 MUSCLE RELAXANT
 [List of Pre Grant Publications for class 514 subclass 907][List of Patents for class 514 subclass 907]907 MUSCULAR DYSTROPHY
 [List of Pre Grant Publications for class 514 subclass 908][List of Patents for class 514 subclass 908]908 LEUKEMIA
[List of Pre Grant Publications for class 514 subclass 909][List of Patents for class 514 subclass 909]909 OBESITY
[List of Pre Grant Publications for class 514 subclass 912][List of Patents for class 514 subclass 912]912 OPHTHALMIC
 [List of Pre Grant Publications for class 514 subclass 916][List of Patents for class 514 subclass 916]916 PYRETIC
 [List of Pre Grant Publications for class 514 subclass 917][List of Patents for class 514 subclass 917]917 RADIOACTIVE, ANTI-
[List of Pre Grant Publications for class 514 subclass 918][List of Patents for class 514 subclass 918]918 REPELLENT
 [List of Pre Grant Publications for class 514 subclass 921][List of Patents for class 514 subclass 921]921 SHOCK
 [List of Pre Grant Publications for class 514 subclass 922][List of Patents for class 514 subclass 922]922 SIDE EFFECT REDUCTION BY INCORPORATION OF A SECOND DESIGNATED INGREDIENT
 [List of Pre Grant Publications for class 514 subclass 923][List of Patents for class 514 subclass 923]923 SLEEP AID (INSOMNIA)
 [List of Pre Grant Publications for class 514 subclass 924][List of Patents for class 514 subclass 924]924 TUBERCULOSIS
[List of Pre Grant Publications for class 514 subclass 925][List of Patents for class 514 subclass 925]925 ULCER TREATMENT
 [List of Pre Grant Publications for class 514 subclass 929][List of Patents for class 514 subclass 929]929 VASODILATOR
 [List of Pre Grant Publications for class 514 subclass 930][List of Patents for class 514 subclass 930]930 VASOCONSTRICTOR (NONDECONGESTANT)
[List of Pre Grant Publications for class 514 subclass 931][List of Patents for class 514 subclass 931]931 VENERAL DISEASE
 [List of Pre Grant Publications for class 514 subclass 935][List of Patents for class 514 subclass 935]935 UTERINE MOTILITY
                 LIQUID CARRIER, DILUENT OR SOLVENT
 [List of Pre Grant Publications for class 514 subclass 936][List of Patents for class 514 subclass 936]936 DMSO CONTAINING
[List of Pre Grant Publications for class 514 subclass 937][List of Patents for class 514 subclass 937]937 DISPERSION OR EMULSION
 [List of Pre Grant Publications for class 514 subclass 944][List of Patents for class 514 subclass 944]944 GEL
 [List of Pre Grant Publications for class 514 subclass 945][List of Patents for class 514 subclass 945]945 FOAM
[List of Pre Grant Publications for class 514 subclass 946][List of Patents for class 514 subclass 946]946 PENETRANT OR ABSORBENT (ENHANCES PENETRATION INTO SUBJECT TREATED)
                 SOLID CARRIER OR SOLID DILUENT
 [List of Pre Grant Publications for class 514 subclass 948][List of Patents for class 514 subclass 948]948 SOLID CANDY TYPE
 [List of Pre Grant Publications for class 514 subclass 949][List of Patents for class 514 subclass 949]949 NATURALLY DERIVED CLAY (E.G., BENTONITE, ETC.)
 [List of Pre Grant Publications for class 514 subclass 950][List of Patents for class 514 subclass 950]950 MACROMOLECULAR (OTHER THAN SYNTHETIC RESINS)
[List of Pre Grant Publications for class 514 subclass 951][List of Patents for class 514 subclass 951]951 POWDERS, GRANULES OR PARTICLES OF SPECIFIED MESH OR PARTICLE SIZE
[List of Pre Grant Publications for class 514 subclass 953][List of Patents for class 514 subclass 953]953 SHAPED FORMS ADAPTED FOR NONINGESTIBLE USE OTHER THAN SUPPOSITORY TYPE (E.G., FILMS, INSERTS, ETC.)
                 GASEOUS OR GAS EMITTING CARRIER OR PROPELLANT
 [List of Pre Grant Publications for class 514 subclass 957][List of Patents for class 514 subclass 957]957 VAPOR EMMITTING COMPOSITION
 [List of Pre Grant Publications for class 514 subclass 958][List of Patents for class 514 subclass 958]958 FOR SMOKING OR INHALING
 [List of Pre Grant Publications for class 514 subclass 959][List of Patents for class 514 subclass 959]959 BREATHING GASES
                 PILL, LOZENGE, TABLET OR CAPSULE
[List of Pre Grant Publications for class 514 subclass 960][List of Patents for class 514 subclass 960]960 SIGNIFICANT, TABLET FORMULATION (E.G., DESIGNATED EXCIPIENT, DISINTEGRANT, GLYDENT OR LUBRICANT, ETC.)
[List of Pre Grant Publications for class 514 subclass 962][List of Patents for class 514 subclass 962]962 CAPSULE (E.G., GELATIN, ETC.)
[List of Pre Grant Publications for class 514 subclass 964][List of Patents for class 514 subclass 964]964 SUSTAINED OR DIFFERENTIAL RELEASE TYPE
                 SUPPOSITORY, BOUGIE OR BASE
 [List of Pre Grant Publications for class 514 subclass 966][List of Patents for class 514 subclass 966]966 RECTAL
 [List of Pre Grant Publications for class 514 subclass 967][List of Patents for class 514 subclass 967]967 VAGINAL
 [List of Pre Grant Publications for class 514 subclass 968][List of Patents for class 514 subclass 968]968 URETHRAL
 [List of Pre Grant Publications for class 514 subclass 969][List of Patents for class 514 subclass 969]969 OINTMENT OR SALVE BASE
                 SPECIAL DESIGNATED INGREDIENT
[List of Pre Grant Publications for class 514 subclass 970][List of Patents for class 514 subclass 970]970 CONTAINING DESIGNATED INGREDIENT TO STABILIZE AN ACTIVE INGREDIENT
 [List of Pre Grant Publications for class 514 subclass 974][List of Patents for class 514 subclass 974]974 CONTAINING DESIGNATED INGREDIENT TO REDUCE NOXIOUS EFFECTS OF ACTIVE INGREDIENT (E.G., TASTE MASKING, ODOR REDUCING, ETC.)
 [List of Pre Grant Publications for class 514 subclass 975][List of Patents for class 514 subclass 975]975 CHARACTERIZED BY THE DESIGNATED SURFACTANT USED
 
FOREIGN ART COLLECTIONS
 
      FOR000          CLASS-RELATED FOREIGN DOCUMENTS
Any foreign patents or non-patent literature from subclasses that have been reclassified have been transferred directly to FOR Collections listed below. These Collections contain ONLY foreign patents or non-patent literature. The parenthetical references in the Collection titles refer to the abolished subclasses from which these Collections were derived.
     DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI)
     Subclass  indent level is 1 Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., O,S,Se or Te) or nitrogen as the only ring hetero atoms DOAI
     Subclass  indent level is 2 Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.)
      FOR104          HETERO RING IS FOUR-MEMBERED AND INCLUDES AT LEAST ONE NITROGEN ATOM (514/210)
      FOR105          HETERO RING IS SEVEN-MEMBERED AND INCLUDES AT LEAST ONE NITROGEN ATOM AND AT LEAST ONE HETERO ATOM OTHER THAN NITROGEN (514/211)
  FOR106          HETERO RING IS SEVEN-MEMBERED CONSISTING OF ONE NITROGEN AND SIX CARBON ATOMS (514/212)
  FOR107          Subclass FOR107 indent level is 1 Polycyclo ring system having the seven-membered hetero ring as one of the cyclos (514/213)
  FOR109          Subclass FOR109 indent level is 1 Peptide containing (e.g., protein, peptones, fibrinogen, etc.) DOAI (514/2)
  FOR110          Subclass FOR110 indent level is 2 Insulin or derivative (514/3)
      FOR112          Subclass FOR112 indent level is 2 Iodine containing (514/5)
      FOR113          Subclass FOR113 indent level is 2 Heavy metal containing (e.g., hemoglobin, etc.) (514/6)
      FOR114          Subclass FOR114 indent level is 2 Phosphorus containing (514/7)
      FOR115          Subclass FOR115 indent level is 2 Glycoprotein (carbohydrate containing) (514/8)
  FOR116          Subclass FOR116 indent level is 2 Cyclopeptides (514/9)
      FOR117          Subclass FOR117 indent level is 3 Bicyclic (514/10)
      FOR118          Subclass FOR118 indent level is 3 Monocyclic (514/11)
      FOR119          Subclass FOR119 indent level is 2 25 or more peptide repeating units in known peptide chain structure (514/12)
      FOR120          Subclass FOR120 indent level is 2 16 to 24 peptide repeating units in known peptide chain (514/13)
      FOR121          Subclass FOR121 indent level is 2 12 to 15 peptide repeating units in known peptide chain (514/14)
      FOR122          Subclass FOR122 indent level is 2 9 to 11 peptide repeating units in known peptide chain (514/15)
      FOR123          Subclass FOR123 indent level is 2 7 or 8 peptide repeating units in known peptide chain (514/16)
      FOR124          Subclass FOR124 indent level is 2 5 or 6 peptide repeating units in known peptide chain (514/17)
      FOR125          Subclass FOR125 indent level is 2 3 or 4 peptide repeating units in known peptide chain (514/18)
  FOR126          Subclass FOR126 indent level is 2 2 peptide repeating units in known peptide chain (514/19)
      FOR127          Subclass FOR127 indent level is 3 Guanidine containing (514/20)
      FOR128          Subclass FOR128 indent level is 2 Produced by or extracted from animal tissue (514/21)
 
DIGESTS
 
 [List of Pre Grant Publications for class 514 subclass DIG1][List of Patents for class 514 subclass DIG1] DIG1 Subclass DIG1 indent level is 1 RU 486 (i.e., RU 38486, RU 486-6, Mifepristone, Mifestone, Mifegyne, (11B-[4-(N, N-dimethylamino) phenyl]-17a-(prop-1-ynyl)-^ 4,9-estradiene-17B-ol-3-one, (11B,17B)11-[4-(dimethylamino)-phenyl]-17-hydroxy-17-(1-propynyl) estra-4,9-dien-3-one)